Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Cancer Chemotherapy and Pharmacology
|
May 19, 2010
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors
F Caponigro, D Lorusso, G Fornari, et al.
Anticancer Research
|
January 4, 2012
Efficacy and feasibility of induction chemotherapy and radiotherapy plus cetuximab in head and neck cancer
M Rampino, A Bacigalupo, E Russi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 30, 2010
Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trial
M Rampino, U Ricardi, F Munoz, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery
|
August 4, 2016
Parameters and outcomes in 525 patients operated on for oral squamous cell carcinoma
P Garzino-Demo, E Zavattero, P Franco, et al.
Anticancer Research
|
May 29, 2008
Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma
C Barone, R Grillo, D Dongiovanni, et al.
The Plant Cell
|
May 16, 2000
Identification of the SAAT gene involved in strawberry flavor biogenesis by use of DNA microarrays
A Aharoni, L C Keizer, H J Bouwmeester, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 8, 2021
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer
S Novello, V Torri, C Grohe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2022
Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66]
S Novello, V Torri, C Grohe, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Cancer Chemotherapy and Pharmacology
|
May 19, 2010
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors
F Caponigro, D Lorusso, G Fornari, et al.
Anticancer Research
|
January 4, 2012
Efficacy and feasibility of induction chemotherapy and radiotherapy plus cetuximab in head and neck cancer
M Rampino, A Bacigalupo, E Russi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 30, 2010
Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trial
M Rampino, U Ricardi, F Munoz, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery
|
August 4, 2016
Parameters and outcomes in 525 patients operated on for oral squamous cell carcinoma
P Garzino-Demo, E Zavattero, P Franco, et al.
Anticancer Research
|
May 29, 2008
Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma
C Barone, R Grillo, D Dongiovanni, et al.
The Plant Cell
|
May 16, 2000
Identification of the SAAT gene involved in strawberry flavor biogenesis by use of DNA microarrays
A Aharoni, L C Keizer, H J Bouwmeester, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 8, 2021
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer
S Novello, V Torri, C Grohe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2022
Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66]
S Novello, V Torri, C Grohe, et al.
Page
of 7